Ask the Doctor: Treating Brain Tumors - KTVN Channel 2 - Reno Tahoe Sparks News, Weather, Video

Ask the Doctor: Treating Brain Tumors

Posted: Updated:
Treating brain tumors without traditional surgery. That's our focus of tonight's Ask the Doctor segment with Dr. Jonathan Tay who is the co-medical director of Reno CyberKnife. 

If you have a question, call 858-2222 between 5 p.m. and 6 p.m. tonight. 

For more information, go to

1) What are the signs to look for signaling you have a brain tumor?

Approximately two-thirds of patients with brain tumors experience symptoms. Patients may experience non-specific symptoms, such as headache, nausea, vomiting, mental status change and lethargy. Other varied symptoms include seizures, paralysis, visual impairment or epileptic seizures. 

2) How does CyberKnife work? It's nothing like traditional surgery right?

CyberKnife robotic stereotactic radiosurgery painlessly delivers precise beams of high-dose radiation to brain tumors and lesions, without incisions, hospitalization, or long recovery time. 

3) Are all brain tumor patients candidates for CyberKnife?

CyberKnife treatment is particularly beneficial for brain tumor patients who have previously received whole brain radiation therapy, as well as patients with tumors near critical areas of the brain. 

4) With CyberKnife, is it just one treatment or is it a series of treatments?

CyberKnife is an outpatient treatment performed in one to five treatment visits with minimal to no side effects. 

5) What's the success rate with CyberKnife?

As numerous clinical studies show, CyberKnife offers an effective treatment option for brain cancer and noncancerous brain tumors and while carrying an extremely low likelihood of negative side effects. CyberKnife's ability to treat tumors and lesions at an extremely precise level makes it an alternative treatment to surgery and conventional radiation therapy
Powered by Frankly
All content © Copyright 2000 - 2018 Sarkes Tarzian, Inc. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.